Risk analysis of coronary heart diseases in Korean adults by using the national cholesterol education program adult treatment panel III

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 3, 2007, Pages 178-182

  Lee, Yong Wha ^a   Min, Won Ki ^b   Lee, Woochang ^b   Chun, Sail ^b   Park, Hyosoon ^c   Lee, Do Hoon ^d   You, Kyoung Lee ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

Adult treatment panel III; Coronary heart disease; Korean; Low density lipoprotein cholesterol; National cholesterol education program; Therapeutic lifestyle change

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; CALCULATION; EDUCATION PROGRAM; FEMALE; GINSENG; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES;

EID: 34249301360     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20165     Document Type: Article

References (20)

1. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med 1988;148:36-69.
2. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1333-1445.
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
4. Gotto AM Jr, High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J 2002;144:S33-S42.
5. Plutzky J. Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr Opin Cardiol 2000; 15:416-421.
6. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The U.S. National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005;67:251-257.
7. Miccoli R, Bianchi C, Odoguardi L, et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis 2005;15:250-254.
8. Heng D, Ma S, Lee JJ, et al. Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis 2006;186:367-373.
9. Takeuchi H, Saitoh S, Takagi S, et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men - the Tanno and Sobetsu Study. Hypertens Res 2005;28:203-208.
10. Stein EA, Myers GL. Lipids, lipoproteins and apolipoproteins. In: Tretz textbook of clinical chemistry, 2nd ed. Philadelphia: WB Saunders; 1994;1002-1034.
11. Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993; 269:3009-3014.
12. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-2369.
13. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-524.
14. Cigarette smoking among adults - United States, 1997. MMWR Morb Mortal Wkly Rep 1999;48:993-996.
15. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
16. Berg K, Dahlen G, Christophersen B, Cook T, Kjekshus J, Pedersen T. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study. Clin Genet 1997;52:254-261.
17. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
18. Tuomilehto J. Reducing coronary heart disease associated with type 2 diabetes: lifestyle intervention and treatment of dyslipidaemia. Diabetes Res Clin Pract 2003;61:S27-S34.
19. Warnick GR, Myers GL, Cooper GR, Rifai N. Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory. Clin Chem 2002;48:11-17.
20. Chun S, Min WK, Park H, et al. The risk groups for coronary heart disease in Koreans. Assessment by distribution of serum lipid concentrations. Clin Chem Lab Med 1999;37:969-974.